secwatch / observer
8-K filed November 10, 2025, 6:59 PM ET ticker MNKD CIK 0000899460
other material confidence high sentiment negative materiality 0.90

MannKind discontinues Phase 3 MNKD-101 trial for NTM lung disease after futility analysis

MANNKIND CORP

item 8.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-25-273321
form_type
8-K
ticker
MNKD
cik
0000899460
company_name
MANNKIND CORP
filed_at
2025-11-10T23:59:59+00:00
discovered_at
2026-05-14T18:02:42.545637+00:00
generated_at
2026-05-16T22:49:49.680787+00:00
sec_items
["8.01"]
event_type
other_material
sentiment
negative
materiality_score
0.9
calibrated_materiality_score
0.9
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-25-273321
json_url
https://secwatch.observer/filing/0001193125-25-273321.json
markdown_url
https://secwatch.observer/filing/0001193125-25-273321.md
text_url
https://secwatch.observer/filing/0001193125-25-273321.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/899460/000119312525273321/0001193125-25-273321-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/899460/000119312525273321/d25083d8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Comparable filings

QMCO

Quantum raises $100M equity, converts all convertible notes to equity; Q4 revenue above guidance

QUANTUM CORP /DE/ June 2, 2026, 10:41 AM ET other_material Items 1.01, 2.02, 2.03, 3.02, 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

CELC

Gedatolisib doubles PFS vs alpelisib in PIK3CA mutant HR+/HER2- ABC Phase 3 trial

Celcuity Inc. June 2, 2026, 8:10 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

CWBHF

Charlotte's Web appoints BAT GC to board, closes debt conversion & US$10M investment

Charlotte's Web Holdings, Inc. June 1, 2026, 5:13 PM ET other_material Items 5.02, 5.07, 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

IDYA

IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma

IDEAYA Biosciences, Inc. June 1, 2026, 4:05 PM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

FULC

Fulcrum Therapeutics discontinues pociredir program in SCD; initiates strategic review

Fulcrum Therapeutics, Inc. June 1, 2026, 4:05 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

CORNER GROWTH ACQUISITION CORP. 2

Corner Growth Acquisition Corp. 2 to liquidate and dissolve after failing to complete business combination

CORNER GROWTH ACQUISITION CORP. 2 June 1, 2026, 4:00 PM ET other_material Items 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

Corner Growth Acquisition Corp.

Corner Growth Acquisition Corp. to liquidate; will redeem public shares

Corner Growth Acquisition Corp. June 1, 2026, 4:00 PM ET other_material Items 8.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

GPRO

GoPro refiles financials with going-concern warning; potential defaults on debt

GoPro, Inc. June 1, 2026, 9:12 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-25-273321
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.